Israel Biotech Fund I, L.P. — Form D
Israel Biotech Fund I, L.P. of TEL AVIV, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2015-10-22. The offering totals $100.0M. Industry: Pooled Investment Fund.
Offering
- Filed: 2015-10-22
- Form: D
- Accession: 0001652458-15-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $100.0M
- Remaining: $100.0M
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-249881
Issuer
- Name: Israel Biotech Fund I, L.P.
- CIK: 0001652458
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2015
- Address: HANNAH RUBINA 11, TEL AVIV, L3, 6937215
- Phone: 972-52-873-9833
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Yuval Cabilly | Executive Officer | Rehovot, L3 |
| David Sidransky | Executive Officer | Germantown, MD |
| Ido Zairi | Executive Officer | Rehovot, L3 |
More